All Q3 FY25 results →
OA

Oriental Aromatics Ltd

Q3 FY25Chemicals & Petrochemicals

Oriental Aromatics Q3 FY25 earnings call: Revenue & Margins

Q3 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹340
Market cap₹1.2K Cr
P/E220.2
Updated23 Aug 2026
Read4 min read

The short version

The company is targeting a revenue milestone of Rs. The company aims to reach Rs.

From Oriental Aromatics Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company is targeting a revenue milestone of Rs. 1,000 crores for the current financial year, with efforts ongoing to achieve this as early as possible, although it may extend to the next year depending on market conditions.
  • Volume growth is expected to be robust, with a 6% year-on-year increase already seen in the recent quarter.
  • Double-digit volume growth is anticipated for FY '26, driven by demand stability globally and new products launched from recently commissioned plants in Baroda and Mahad.
  • The Specialty Aroma Ingredients and Fragrance divisions are showing significant growth in both value and volume.

2 more points from Oriental Aromatics Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Oriental Aromatics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Currently, there are no new plans for additional capacity or new plants beyond the recently commissioned ones. (Page 9)
  • The recent expansions include the Mahad plant and the hydrogenation plant at Baroda, which are part of ongoing growth and consolidation efforts. (Pages 15-16)
  • The Mahad facility is recently commissioned and expected to reach about 40-50% utilization initially, ramping up substantially in coming quarters. (Page 10)
  • The hydrogenation plant is expected to achieve 60-70% utilization by end of FY 2025 and reach optimal levels by FY 2026. (Page 10)

2 more points from Oriental Aromatics Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Oriental Aromatics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company is currently focusing on consolidating launched products rather than expanding new programs.
  • Significant contracts related to the new products, especially from the Mahad plant, are anticipated primarily in Q1 of the next financial year (FY 2026) when bidding for calendar year 2025 H2 contracts takes place.
  • Initial sales in Q4 will mainly be spot sales to customers.
  • The business model emphasizes generic products rather than patented ones, ensuring freedom to operate and supplier relationships with major innovation-driven companies.

2 more points from Oriental Aromatics Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Oriental Aromatics Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹282 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Himadri Special (Q3 FY25)

    1,131.81 Crs, up 7.53% YoY (from Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Gujarat Alkalies (Q3 FY25)

    3,702.77 Crores (up from Rs. Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Balaji Amines (Q3 FY25)

    Q3FY25 consolidated revenue from operations was ₹321 crore, down 18% YoY from ₹392 crore in Q3FY24 (Page 7). Key concall takeaways from Balaji Amines Ltd's Q3…

  • Vidhi Specialty Food Ingredients Ltd (Q3 FY25)

    Year-on-Year (Y-o-Y) Growth:** 56.5% increase . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY25 earnings call — and how it ranks…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Oriental Aromatics Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Oriental Aromatics Ltd Q3 FY25 results?

The company is targeting a revenue milestone of Rs. The company aims to reach Rs.

What is Oriental Aromatics Ltd share price analysis?

Oriental Aromatics Ltd currently shows a neutral. The stock trades at a P/E of 220.2 with a market cap of ₹1,171 Cr. Investors should review the full earnings analysis for detailed insights.

Is Oriental Aromatics Ltd planning capital expenditure?

Currently, there are no new plans for additional capacity or new plants beyond the recently commissioned ones.

Keep Oriental Aromatics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.